Site Map
Showing posts with label CNBC Early Movers.. Show all posts
Showing posts with label CNBC Early Movers.. Show all posts

Dec 16, 2016

CNBC Early Movers - December 16, 2016: HON, TRVG, JWN, BID, CLX, GE, ORCL, and More

Peter Schacknow

Traders work on the floor of the New York Stock Exchange.
Brendan McDermid | Reuters
Traders work on the floor of the New York Stock Exchange.
Check out which companies are making headlines before the bell:
Honeywell — Honeywell shares are under pressure after Honeywell said its current-quarter earnings would come in at the low end of its prior forecast, and gave a 2017 earnings outlook that falls largely below estimates. The company did give upbeat comments about 2017, despite what it sees as a slow growth global environment.
Trivago — The hotel search website operator saw its initial public offering price at $11 per share, below the expected range of $13 to $15 a share. Trivago raised a total of $287 million in the offering.
Nordstrom — JPMorgan Chase downgraded the retailer to "underweight" from "neutral" following meetings with management, and based its decision on relatively flat sales and no "silver bullets" on the horizon to improve trends.
Sotheby's — Cowen upgraded the auction house to "outperform" from "market perform" due to what it calls an improving business model and market environment.
Clorox — BMO began coverage on the consumer products maker with an "outperform" rating, noting a recent pullback in the share price represents a buying opportunity. BMO is upbeat on Clorox's product portfolio as well as the ability to make strategic acquisitions.
General Electric — The Dow component was upgraded to "outperform" from "market perform" at Bernstein, noting a positive transformation in GE's asset portfolio and underperformance by the shares this year.
Oracle — Oracle adjusted quarterly earnings of 61 cents per share, one cent above estimates, while the business software maker's revenue was slightly below Street forecasts. Executive chairman Larry Ellison highlighted the company's passing rival Salesforce in cloud-based revenue, but the shares are under pressure with investors apparently disappointed at the cloud unit's rate of growth.
Adobe Systems — Adobe beat estimates by four cents with adjusted quarterly profit of 90 cents per share, while revenue was slightly above forecasts. Adobe's quarterly was highlighted by a 39 percent jump in subscription revenue, although it did project 2017 earnings that fall slightly below Street consensus.
Gilead Sciences — Gilead was ordered to pay Merck $2.5 billion in damages for patent infringement involving hepatitis C drugs. Gilead said it "respectfully disagrees" with the jury's verdict and damage award and plans to appeal.
Priceline Group — Priceline named its strategy chief Glenn Fogel as its next Chief Executive Officer, effective January 1. Chairman Jeff Boyd has served as interim CEO for the travel website operator following the firing of CEO Darren Huston earlier this year. Boyd will continue to serve as executive chairman.
Dow Chemical — Dow gained the right to convert $4 billion of preferred stock into common shares, after a rally in Dow's share price triggered conversion rights. That means Dow Chemical will no longer have to pay $255 million per year to Berkshire Hathaway and $85 million to Kuwait's sovereign wealth fund, which both hold the preferred shares.
Harman International — Harman may see a higher takeover bid, according to The Wall Street Journal's Heard On The Street column, as Samsung's current $8 billion deal faces shareholder opposition. The column speculates that other companies like Microsoft or Alphabet might swoop in to bid for the auto parts maker in an attempt to further their efforts involving self-driving vehicles.
Yahoo — Yahoo remains on our watch list, with increasing speculation that Verizon may demand changes or cancel its deal to buy Yahoo's internet assets following the revelation of another data breach.
Agio Pharmaceuticals — Agio is discontinuing the development of a second drug to treat a rare form of anemia. The move follows the FDA's action to put a study of the drug on hold, although Agio said it is still working on another drug designed to treat that condition.
Las Vegas Sands — The stock was added to the Conviction Buy list at Goldman Sachs, with casino rival MGM Resorts earning a "buy" rating in the same report. Wynn Resorts was rated at "neutral." Goldman likes Las Vegas Sands in particular for its potential to benefit from rebounds in both Las Vegas and Macau.
Jabil Circuit — The electronics manufacturer came in five cents above estimates with adjusted quarterly profit of 69 cents per share, with revenue also beating forecasts. It did particularly well in its diversified manufacturing services business, which includes Apple among its customers. 

Latest Post Published

The Crypto Today | Wednesday, May 18, 2022: